NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Earnings Estimates
Europe - Frankfurt Stock Exchange - FRA:NZM2 - DK0060336014 - Common Stock
54.16 EUR
-0.28 (-0.51%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.351B 17.25% | 2.397B 1.97% | 3.834B 59.91% | 4.232B 10.40% | 4.527B 6.97% | 4.849B 7.11% | 5.244B 8.15% | 5.624B 7.25% | 5.92B 5.26% | 6.23B 5.24% | 6.55B 5.14% | 6.895B 5.27% | |
| EBITDA YoY % growth | 795.701M 11.05% | 783.915M -1.48% | 1.256B 60.27% | 1.561B 24.24% | 1.701B 8.97% | 1.851B 8.82% | 2.022B 9.24% | 2.186B 8.11% | 2.311B 5.72% | 2.435B 5.37% | 2.566B 5.38% | 2.701B 5.26% | |
| EBIT YoY % growth | 596.81M 13.33% | 597.881M 0.18% | 659M 10.22% | 994.75M 50.95% | 1.139B 14.50% | 1.281B 12.47% | 1.351B 5.46% | 1.435B 6.22% | 1.59B 10.80% | 1.692B 6.42% | 1.798B 6.26% | 1.908B 6.12% | |
| Operating Margin | 25.39% | 24.94% | 17.19% | 23.51% | 25.16% | 26.42% | 25.76% | 25.52% | 26.86% | 27.16% | 27.45% | 27.67% | |
| EPS YoY % growth | 1.77 17.51% | 1.46 -17.70% | N/A -10.56% | 1.89 44.83% | 2.05 8.23% | 2.28 11.47% | 2.53 10.71% | 2.75 8.80% | 3.00 9.25% | 3.17 5.61% | 3.36 5.75% | 3.55 5.74% |
All data in EUR
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | 0.64 77.79% |
| Revenue Q2Q % growth | 1.004B -49.85% |
| EBITDA Q2Q % growth | 370.17M -50.84% |
| EBIT Q2Q % growth | 291.89M -32.98% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.54 49.34% | 0.37 | 0.17 | 45.68% |
| Q2 2025 Q2Q % growth | 0.47 45.88% | 0.41 | 0.06 | 14.06% |
| Q1 2025 Q2Q % growth | 0.42 30.36% | 0.39 | 0.03 | 6.35% |
| Q4 2024 Q2Q % growth | 7.40% | 0.36 | % | |
| Q3 2024 Q2Q % growth | -20.06% | 0.36 | % | |
| Q2 2024 Q2Q % growth | 10.07% | 0.32 | % | |
| Q1 2024 Q2Q % growth | -14.99% | 0.32 | % | |
| Q4 2023 Q2Q % growth | 0.34 -21.27% | 0.39 | -0.06 | -14.49% |
| Q3 2023 Q2Q % growth | 0.45 -18.75% | 0.38 | 0.08 | 20.08% |
| Q2 2023 Q2Q % growth | 0.29 -24.93% | 0.37 | -0.07 | -19.98% |
| Q1 2023 Q2Q % growth | 0.38 -5.39% | 0.38 | 0.00 | -1.01% |
| Q4 2022 Q2Q % growth | 0.43 41.96% | 0.37 | 0.06 | 15.90% |
| Q3 2022 Q2Q % growth | 0.56 37.50% | 0.53 | 0.03 | 5.90% |
| Q2 2022 Q2Q % growth | 0.39 2.44% | 0.37 | 0.02 | 4.53% |
| Q1 2022 Q2Q % growth | 0.40 -5.45% | 0.40 | 0.00 | -0.77% |
| Q4 2021 Q2Q % growth | 0.30 -3.79% | 0.31 | -0.01 | -2.86% |
| Q3 2021 Q2Q % growth | 0.40 19.10% | 0.34 | 0.06 | 19.05% |
| Q2 2021 Q2Q % growth | 0.38 24.49% | 0.34 | 0.04 | 10.88% |
| Q1 2021 Q2Q % growth | 0.42 9.89% | 0.34 | 0.09 | 25.11% |
| Q4 2020 Q2Q % growth | 0.31 | 0.34 | -0.02 | -7.18% |
| Q3 2020 Q2Q % growth | 0.34 | 0.33 | 0.01 | 4.43% |
| Q2 2020 Q2Q % growth | 0.31 | 0.31 | -0.01 | -1.75% |
| Q1 2020 Q2Q % growth | 0.39 | 0.38 | 0.00 | 0.58% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.065B 5.54% | 1.079B | -14.1M | -1.31% |
| Q2 2025 Q2Q % growth | 1.019B -44.40% | 1.042B | -23.5M | -2.26% |
| Q1 2025 Q2Q % growth | 1.078B 4.62% | 1.074B | 3.6M | 0.34% |
| Q4 2024 Q2Q % growth | 2.002B 224.28% | 1.002B | 1B | 99.78% |
| Q3 2024 Q2Q % growth | 68.85% | 1.009B | % | |
| Q2 2024 Q2Q % growth | 1.832B -56.56% | 980.17M | 851.53M | 86.88% |
| Q1 2024 Q2Q % growth | -77.72% | 1.03B | % | |
| Q4 2023 Q2Q % growth | 617.312M -86.37% | 625.01M | -7.698M | -1.23% |
| Q3 2023 Q2Q % growth | 597.574M -86.32% | 596.24M | 1.334M | 0.22% |
| Q2 2023 Q2Q % growth | 4.217B -1.61% | 593.32M | 3.624B | 610.75% |
| Q1 2023 Q2Q % growth | 4.623B 5.77% | 614.95M | 4.008B | 651.77% |
| Q4 2022 Q2Q % growth | 4.529B 18.13% | 614.49M | 3.915B | 637.03% |
| Q3 2022 Q2Q % growth | 4.367B 16.11% | 596.3M | 3.771B | 632.35% |
| Q2 2022 Q2Q % growth | 4.286B 19.72% | 549.89M | 3.736B | 679.43% |
| Q1 2022 Q2Q % growth | 4.371B 15.76% | 567.95M | 3.803B | 669.61% |
| Q4 2021 Q2Q % growth | 3.834B 11.26% | 508.52M | 3.325B | 653.95% |
| Q3 2021 Q2Q % growth | 3.761B 9.62% | 499.87M | 3.261B | 652.40% |
| Q2 2021 Q2Q % growth | 3.58B 6.90% | 478.37M | 3.102B | 648.37% |
| Q1 2021 Q2Q % growth | 3.776B -0.26% | 478.23M | 3.298B | 689.58% |
| Q4 2020 Q2Q % growth | 3.446B | 480.98M | 2.965B | 616.45% |
| Q3 2020 Q2Q % growth | 3.431B | 473.42M | 2.958B | 624.73% |
| Q2 2020 Q2Q % growth | 3.349B | 453.29M | 2.896B | 638.82% |
| Q1 2020 Q2Q % growth | 3.786B | 506.08M | 3.28B | 648.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -22.85% | 0.01% | 2.65% |
| Revenue | -1.28% | -4.74% | 0% | 0.36% |